Eliem Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
PIMBLETT EMILY officer: CHIEF ACCOUNTING OFFICER
Common Stock 1,245 $7.22 $8,983
Option
PIMBLETT EMILY officer: CHIEF ACCOUNTING OFFICER
Restricted Stock Units 5,000 N/A N/A
Option
PIMBLETT EMILY officer: CHIEF ACCOUNTING OFFICER
Common Stock 5,000 N/A N/A
Option
MORISSET VALERIE officer: EVP, R&D AND CSO
Common Stock 17,847 N/A N/A
Option
MORISSET VALERIE officer: EVP, R&D AND CSO
Stock Option (Right to Buy) 17,847 N/A N/A
Option
PIMBLETT EMILY officer: CHIEF ACCOUNTING OFFICER
Restricted Stock Units 40,000 N/A N/A
Option
MORISSET VALERIE officer: EVP, R&D AND CSO
Common Stock 15,297 N/A N/A
Option
MORISSET VALERIE officer: EVP, R&D AND CSO
Common Stock 5,431 $0 $11
Option
MORISSET VALERIE officer: EVP, R&D AND CSO
Stock Option (Right to Buy) 15,297 N/A N/A
Option
MORISSET VALERIE officer: EVP, R&D AND CSO
Stock Option (Right to Buy) 5,431 $0 $11
Option
MORISSET VALERIE officer: EVP, R&D and CSO
Stock Option (Right to Buy) 61,191 N/A N/A
Option
MORISSET VALERIE officer: EVP, R&D and CSO
Stock Option (Right to Buy) 255,219 $0 $510
Option
MORISSET VALERIE officer: EVP, R&D and CSO
Common Stock 61,191 N/A N/A
Option
MORISSET VALERIE officer: EVP, R&D and CSO
Common Stock 255,219 $0 $510
Purchase
RA CAPITAL MANAGEMENT, L.P. director, 10 percent owner
Common Stock 3,200,000 $12.5 $40,000,000
Purchase
AI ETI LLC 10 percent owner
Common Stock 800,000 $12.5 $10,000,000

Showing 1 to 16 of 16 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.